Preventive medical check-ups during pregnancy in Austria;Vorsorgeuntersuchungen in der Schwangerschaft in Österreich

Gynakologisch-geburtshilfliche Rundschau

Volumn 49, Issue 4, 2009, Pages 277-286

  Ulrich, Daniela ^a   Schneuber, Susanne ^a   Lang, Uwe ^a   Schlembach, Dietmar ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Mother child pass; Preventive pregnancy check up

Indexed keywords

ADULT; AMNIOCENTESIS; AUSTRIA; CHILD CARE; CHORION VILLUS SAMPLING; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS MORTALITY; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; MATERNAL CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PERINATAL MORBIDITY; PRENATAL CARE; PRENATAL SCREENING; PREVENTIVE HEALTH SERVICE; REGISTRATION; REVIEW;

AUSTRIA; CONGENITAL ABNORMALITIES; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MASS SCREENING; NATIONAL HEALTH PROGRAMS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; ULTRASONOGRAPHY, PRENATAL;

EID: 77953190148     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000301089     Document Type: Review

References (60)

1. Cedergren M: Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 2006; 93: 269-274.
2. AG Schwangerschaftshochdruck/Gestose der DGGG: Diagnostik und Therapie hypertensvier Schwangerschaftserkrankungen. AWMF-Leitlinie 015/018. 2007. http://www. dggg.de/-download/unprotected/g-04-03-06-hypertensiver-schw- erkrankungen.pdf.
3. Mohaupt M: Ödeme in der Schwangerschaft - banal? Ther Umsch 2004; 61: 687-690.
4. Davison JM: Edema in pregnancy. Kidney Int Suppl 1997; 59:S90-S96.
5. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
6. Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, Curtis KM: Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197: 223-228. (Pubitemid 47361949)
7. Rondó PH, Maia Filho NL, Valverde KK: Symphysis-fundal height and size at birth. Int J Gynaecol Obstet 2003; 81: 53-54.
8. Mongelli M, Gardosi J: Estimation of fetal weight by symphysis-fundus height measurement. Int J Gynaecol Obstet 2004; 85: 50-51.
9. Thompson ML, Theron GB, Fatti LP: Predictive value of conditional centile charts for weight and fundal height in pregnancy in detecting light for gestational age births. Eur J Obstet Gynecol Reprod Biol 1997; 72: 3-8.
10. Haram K, Softeland E, Bukowski R: Intrauterine growth restriction. Int J Gynaecol Obstet 2006; 93: 5-12.
11. Viehweg B: Schwangerenvorsorge; in Schneider H, Husslein P, Schneider KTM (Hrsg): Die Geburtshilfe, Aufl 2. Berlin, Springer, 2004, p 185.
12. Schlemach D: Urine analysis in pregnancy. Ther Umsch 2006; 63: 585-589.
13. AG Diabetes und Schwangerschaft der Deutschen Diabetes-Gesellschaft und der AGMFM der DGGG, DGPM: Diagnostik und Therapie des Gestationsdiabetes (GDM). AWMF-Leitlinie 057/008. 2006. http://www. dggg.de/-download/unprotected/g-04-03- 04-diagnostik-therapie-gdm.pdf.
14. Klein LL, Gibbs RS: Use of microbial cultures and antibiotics in the prevention of infection- associated preterm birth. Am J Obstet Gynecol 2004; 190: 1493-1502.
15. Mendling W: Bakterielle Infektionen; in Mendling W (Hrsg): Vaginose, Vaginitis, Zervizitis und Salpingitis, Aufl 2. Heidelberg, Springer, 2006, pp 22-52.
16. Saling E, Raitsch S, Placht A, Fuhr N, Schumacher G: Frühgeburten- Vermeidungs- Programm und Selbstvorsorge - Aktion für Schwangere. Frauenarzt 1994; 35: 84-92.
17. Ugwumadu A, Manyonda I, Reid F, Hay P: Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003; 361: 983-988.
18. McDonald HM, Brocklehurst P, Gordon A: Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007; 1:CD000262.
19. Carey JC, Klebanoff MA: Is the change in the svaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol 2005; 192: 1341-1347.
20. Breymann C: Anämie; in Schneider H, Husslein P, Schneider KTM (Hrsg): Die Geburtshilfe, Aufl 2. Berlin, Springer, 2004, pp 322-333.
21. Report of the UNICEF/WHO Regional Consultation: Prevention and control of iron deficiency anaemia in women and children. Geneva, WHO, 1999
22. Centers for Disease Control and Prevention: Recommendations to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998; 47: 1-30.
23. Ziaei S, Norrozi M, Faghihzadeh S, Jafarbegloo E: A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin 1 or = 13.2 g/dl. Br J Obstet Gynaecol 2007; 114: 684-688. (Pubitemid 46788644)
24. Levy A, Fraser D, Katz M, Mazor M, Sheiner S: Maternal anemia during pregnancy is an independent risk factor for low birth weight and preterm delivery. Eur J Obstet Gynecol Reprod Biol 2005; 122: 182-186.
25. Letsky EA: Maternal anaemia in pregnancy, iron and pregnancy - a haematologist's viewpoint. Fetal Matern Med Rev 2001; 12: 159-175.
26. Williams MD, Wheby MS: Anemia in pregnancy. Med Clin North Am 1992; 76: 631-647.
27. Engelfriet CP, Reesink HW, Judd WJ, Ulander VM, Kuosmanen M, Koskinen S, Rouger P, Morelati F, Tantalo V, Fujii T, de Haas M, van der Schoot CE, Overbeeke M, Koelewijn J, Bonsel G, Vrijkotte T, Zupaska B, Martin- Vega C, Parra Lopez R, de Silva M, Contreras M, Panzer S, Ulm B, Mayr WR: Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang 2003; 85: 328-337.
28. Crowther CA, Keirse MJ: Anti-D administration in pregnancy for preventing rhesus alloimmunisation. Cochrane Database Syst Rev 2000; 2:CD000020.
29. Friese K: Infektionsscreening in der Schwangerschaft. Gynäkologe 2004; 35: 669-673.
30. Petersen E: Toxoplasmosis. Semin Fetal Neonatal Med 2007; 12: 214-223.
31. Thiébaut R, Leproust S, Chene G, Gilbert R, SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group: Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007; 369: 115-122.
32. Khoshnood B, De Vigan C, Goffinet F, Leroy V: Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening. Prenat Diagn 2007; 27: 395-403.
33. Chang MH: Hepatitis B virus infection. Semin Fetal Neonatal Med 2007; 12: 160-167.
34. Plitt SS, Somily AM, Singh AE: Outcomes from a Canadian public health prenatal screening program for hepatitis B: 1997- 2004. Can J Public Health 2007; 98: 194-197.
35. Parasher K, Bartsch M, Gstettenbauer M, Entezami M, Versmold H, Stück B: Generelles Hepatitis-B-Screening in der Schwangerschaft - noch immer ein ungelöstes Problem in der Geburtshilfe. Dtsch Ärztebl 2001; 98:A329-A333.
36. Jamieson DJ, Clark J, Kourtis AP, Taylor AW, Lampe MA, Fowler MG, Mofenson LM: Recommendations for human immunodeficiency virus screening, prophylaxis and treatment for pregnant women in the United States. Am J Obstet Gynecol 2007; 197 (suppl):S26-S32.
37. Moser F, Tamussino K, Häusler M, Puchhammer E: HIV-Screening in Gynäkologie und Geburtshilfe. Geburtsh Frauenheilkd 2001; 61: 209-212.
38. Matijevic R, Grgic O, Vasilj O: Is sonographic assessment of cervical length better than digital examination in screening for preterm delivery in a low-risk population? Acta Obstet Gynecol Scand 2006; 85: 1342-1347.
39. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A: Prevention of perinatal group B streptococcal disease - revised guidelines from CDC. MMWR Morb Mortal Wkly Rep 2002; 51: 1-22.
40. Pettersson K: Perinatal infection with group B streptococci. Semin Fetal Neonatal Med 2007; 13: 193-197.
41. Royal College of Obstetricians and Gynaecologists and London School of Hygiene and Tropical Medicine: The prevention of earlyonset neonatal group B streptococcal disease in UK obstetric units. January 2007.
42. Witt A, Kiss H: Leitlinie der Medizinischen Universität Wien: hämolysierende Streptokokken der Gruppe B in der Schwangerschaft. Gyn-Aktiv 2000; 2: 46.
43. Kovavisarach E, Sa-adying W, Kanjanahareutai S: Comparison of combined vaginalanorectal, vaginal and anorectal cultures in detecting of group B streptococci in pregnant women in labor. J Med Assoc Thai 2007; 90: 1710-1714.
44. Quinlan JD: The necessity of both anorectal and vaginal cultures for group B streptococcus screening during pregnancy. J Fam Pract 2000; 49: 447-448.
45. Häusler M, Husslein P, Leodolter S, Speiser P, Stummvoll W, Krampl E, Steiner H, Deutinger J, Auer B, Braune G, Hochmaier G, Lassmann R: Ultraschall in der Schwangerschaft. Eine Information der OeGGG, der ÖGUM, der ÖGPPM und der ÖAK. Speculum 2007; 25: 1-16.
46. Standardkommission der Deutschen Gesellschaft für Perinatale Medizin, AG MFM der DGGG, DEGUM III, Board für Pränatalund Geburtsmedizin: Standards in der Perinatalmedizin - Dopplersonographie in der Schwangerschaft. Geburtshilfe Frauenheilkd 2003; 63: 21-25.
47. Eiben B, Hackelöer BJ, Huesgen G, Kozlowski P, Merz E, Osmers R, Wagner H: Pränatale Risikopräzisierung im ersten Trimenon der Schwangerschaft über Messung der fetalen Nackentransparenz und biochemische Analyse aus dem maternalen Serum. Ikon 2002; 11: 2-8.
48. Eiben B, Glaubitz R: First-trimester screening: an overview. J Histochem Cytochem 2005; 53: 281-283.
49. Prefumo F, Sairam S, Bhide A, Thilaganathan B: First-trimester nuchal translucency, nasal bones and trisomy 21 in selected and unselected populations. Am J Obstet Gynecol 2006; 194: 828-833.
50. Sonek JD, Cicero S, Neiger R, Nicolaides KH: Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol 2006; 195: 1219-1230. (Pubitemid 44635344)
51. Caughey AB, Hopkins LM, Norton ME: Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108: 612-616.
52. Towner D, Currier RJ, Lorey FW, Cunningham GC, Greve LC: Miscarriage risk from amniocentesis performed for abnormal maternal serum screening. Am J Obstet Gynecol 2007; 196: 608.e1-608.e5.
53. Jensen DM, Korsholm L, Ovesen P, Beck- Nielsen H, Molsted-Pedersen L, Damm P: Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008; 87: 59-62.
54. Langer O: From educated guess to accepted practice: the use of antidiabetic agents in pregnancy. Clin Obstet Gynecol 2007; 50: 959-971.
55. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, Oats JJ, Persson B, Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy outcome. N Engl J Med 2008;358:1991-2002.
56. Bühling KJ, Mönnich J, Henrich W, Brauer M, Heinze T, Siebert G, Dudenhausen JW: Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations. Z Geburtshilfe Neonatol 2004; 208: 226-231.
57. Weiss PA, Häusler M, Tamussino K, Haas J: Can glucose tolerance test predict fetal hyperinsulinism? Br J Obstet Gynaecol 2000; 107: 1480-1485.
58. Weiss PA, Scholz HS, Haas J, Tamussino KF: Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 2001; 184: 470-475.
59. Weiss P, Hoffmann H: Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch Gynecol 1986; 239: 81-91.
60. Schneider KTM, Butterwegge M, Daumer M, Dudenhausen J, Gonser M, Husslein P, Hecher K, Jensen A, Rath W, Schmidt S, Vetter K, Zimmermann R, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. - Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Arbeitsgruppe der Deutschen Gesellschaft für Perinatale Medizin und der AG für Maternofetale Medizin: Anwendung des CTG während Schwangerschaft und Geburt. http://www. uni-duesseldorf.de/awmf/II/015-036.htm.